Paul S - Search Results

1

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses.

Gutjahr A, Papagno L, Vernejoul F, Lioux T, Jospin F, Chanut B, Perouzel E, Rochereau N, Appay V, Verrier B, Paul S. Gutjahr A, et al. Among authors: paul s. EBioMedicine. 2020 Aug;58:102922. doi: 10.1016/j.ebiom.2020.102922. Epub 2020 Jul 30. EBioMedicine. 2020. PMID: 32739871 Free PMC article.

2

Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells.

Primard C, Rochereau N, Luciani E, Genin C, Delair T, Paul S, Verrier B. Primard C, et al. Among authors: paul s. Biomaterials. 2010 Aug;31(23):6060-8. doi: 10.1016/j.biomaterials.2010.04.021. Epub 2010 May 14. Biomaterials. 2010. PMID: 20471085

3

Phenotypic localization of distinct DC subsets in mouse Peyer Patch.

Rochereau N, Verrier B, Pin JJ, Genin C, Paul S. Rochereau N, et al. Among authors: paul s. Vaccine. 2011 May 9;29(20):3655-61. doi: 10.1016/j.vaccine.2011.03.012. Epub 2011 Mar 23. Vaccine. 2011. PMID: 21439318

4

New insights in mucosal vaccine development.

Pavot V, Rochereau N, Genin C, Verrier B, Paul S. Pavot V, et al. Among authors: paul s. Vaccine. 2012 Jan 5;30(2):142-54. doi: 10.1016/j.vaccine.2011.11.003. Epub 2011 Nov 12. Vaccine. 2012. PMID: 22085556 Review.

5

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

Benjelloun F, Lawrence P, Verrier B, Genin C, Paul S. Benjelloun F, et al. Among authors: paul s. J Virol. 2012 Dec;86(24):13152-63. doi: 10.1128/JVI.01110-12. Epub 2012 Sep 26. J Virol. 2012. PMID: 23015715 Free PMC article. Review.

6

Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.

Pavot V, Rochereau N, Primard C, Genin C, Perouzel E, Lioux T, Paul S, Verrier B. Pavot V, et al. Among authors: paul s. J Control Release. 2013 Apr 10;167(1):60-7. doi: 10.1016/j.jconrel.2013.01.015. Epub 2013 Jan 23. J Control Release. 2013. PMID: 23352911

7

Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.

Benjelloun F, Dawood R, Urcuqui-Inchima S, Rochereau N, Chanut B, Verrier B, Lucht F, Genin C, Paul S. Benjelloun F, et al. Among authors: paul s. AIDS. 2013 Jul 31;27(12):1992-5. doi: 10.1097/QAD.0b013e3283632ea1. AIDS. 2013. PMID: 23696073

8

Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex.

Dawood R, Benjelloun F, Pin JJ, Kone A, Chanut B, Jospin F, Lucht F, Verrier B, Moog C, Genin C, Paul S. Dawood R, et al. Among authors: paul s. AIDS. 2013 Mar 13;27(5):717-30. doi: 10.1097/QAD.0b013e32835cfca5. AIDS. 2013. PMID: 23719346

9

Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells.

Rochereau N, Drocourt D, Perouzel E, Pavot V, Redelinghuys P, Brown GD, Tiraby G, Roblin X, Verrier B, Genin C, Corthésy B, Paul S. Rochereau N, et al. Among authors: paul s. PLoS Biol. 2013 Sep;11(9):e1001658. doi: 10.1371/journal.pbio.1001658. Epub 2013 Sep 17. PLoS Biol. 2013. PMID: 24068891 Free PMC article.

10

Recent progress in HIV vaccines inducing mucosal immune responses.

Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S. Pavot V, et al. Among authors: paul s. AIDS. 2014 Jul 31;28(12):1701-18. doi: 10.1097/QAD.0000000000000308. AIDS. 2014. PMID: 25009956 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,421 results

Search Page

Filters